Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 359Neoplasms 327Prostatic Neoplasms 267Colorectal Neoplasms 261Multiple Myeloma 204Lung Neoplasms 195Neoplasm Metastasis 183Leukemia, Myeloid, Acute 158Ovarian Neoplasms 151Pancreatic Neoplasms 143Squamous Cell Carcinoma of Head and Neck 134Melanoma 125Recurrence 99Carcinoma, Renal Cell 99Glioblastoma 96Endometrial Neoplasms 96Stomach Neoplasms 93Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Lymphoma, Non-Hodgkin 92Carcinoma, Hepatocellular 92Head and Neck Neoplasms 91Lymphoma 88Triple Negative Breast Neoplasms 84Uterine Cervical Neoplasms 80Brain Neoplasms 79Sarcoma 78Glioma 75Urinary Bladder Neoplasms 74Lymphoma, Large B-Cell, Diffuse 74

Interventions

Tablets 1Fulvestrant 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Genetic Diseases, Inborn × 30 days × Clear all
NCT06089954 2026-05-26

ROR

Abramson Cancer Center at Penn Medicine

Phase NA Active not recruiting
2,500 enrolled

Cardiovascular Diseases, Neoplasms, Genetic Diseases, Inborn

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡